Hi Wayne,
Yes, an excellent article.
You wrote;
I gathered from the article that the scientists are looking for validation of a technology which will source macrocycles;
After reading the review, I was thinking that if Phylogica wanted to discover macrocyclic CPPs there's a strong possibility that the two technologies they are looking to validate i.e., the Endosomal Escape and the Macrocycle Technology could potentially be used together. Now wouldn't that differentiate the company from its peers?
Exciting times ahead!
Regards,
Tony
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.005(0.34%) |
Mkt cap ! $842.8M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.40 | $451.6K | 315.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10001 | $1.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 3114 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |